Details for 2013707527

Up to date per 04.04.2026

Actions

Title / Product Name

KREBSPATIENTENAUSWAHL ZUR VERABREICHUNG VON WNT-SIGNALÜBERTRAGUNGSHEMMERN UNTER VERWENDUNG EINER RNF43-STATUS-MUTATION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013707527

EP Publication Number

2820151

E-Number

1248600

Language

PCT Number

US13027441

Publication Date

07.01.2015 A

25.03.2020 B1

Registration Date

25.03.2020

AT Publication Date

15.04.2020

Application Date

22.02.2013

Registration Number

Priorities

28.02.2012

201261604290 P

IPC

C12Q 1/68 20180101AFI20130919BHEP

Maximum Duration of Protection

22.02.2033

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CONG, FengNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

HAO, HuaixiangNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

HSIEH, Hsin-iGenomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, CA 92121US

JIANG, XiaomoNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

LIU, JunGenomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, CA 92121US

NG, NicholasGenomics Institute of the Novartis Research Foundation 10675 John Jay Hopkins Drive San Diego, CA 92121US